The new device, which bears the name “endoscopic mass spectrometer,” represents a qualitative achievement in the field of medical diagnosis, as it can distinguish high-risk from low-risk tumors during the endoscopic process, without the need for additional procedures or repeated biopsies.

This innovation, which was accomplished under the supervision of Dr. Muhammad Abdel-Ahad and Dr. Reyhaneh Mahdavi from the Faculty of Engineering at the University of Tehran, and Dr. Reza Taslimi and Dr. Ruhollah Miri from the Faculty of Medicine at Tehran University of Medical Sciences, aims to increase the accuracy of diagnosis and reduce errors resulting from relying on visual observation or traditional histological analyses.

She said Dr. Mahdavi Cancers Digestive system It often passes without obvious symptoms in its early stages, which makes early diagnosis crucial to saving patients’ lives. She explained that the new system is used integrated with a traditional endoscope, and allows immediate electrical analysis of tissues without disrupting the process or requiring additional tools.

The results of clinical trials conducted on 52 patients showed a high accuracy of the device, with sensitivity reaching 94.7%, specificity 93.9%, and overall accuracy 94.2%, which confirms its ability to speed up diagnosis, reduce the number of unnecessary biopsies, and enhance the chances of early detection and effective treatment.

This innovation is an advanced step towards employment Engineering intelligence And biotechnology to serve accurate medical diagnosis, and opens new horizons for developing less invasive and effective tools for detecting cancer early.